Blueprint Medicines Corp (BPMC) — Cash Flow Quality Index
Blueprint Medicines Corp (BPMC) has a Cash Flow Quality Index of -109.84x as of March 2025. Operating cash flow of $-54.48 Million is below net income of $496.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Blueprint Medicines Corp debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Blueprint Medicines Corp Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for Blueprint Medicines Corp across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Blueprint Medicines Corp (BPMC) cash conversion ratio.
Annual Cash Flow Quality Index for Blueprint Medicines Corp (2020–2020)
Year-by-year earnings quality comparison for Blueprint Medicines Corp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.23x | $387.04 Million | $313.88 Million | — |